Oral Diseases (2010) 17, 13–25 HIV infection remains a global health problem of
unprecedented dimensions, although the development of highly active antiretroviral therapy …

The purpose of the present study paper was to review the reported prevalence of the oral
manifestations of HIV (OM‐HIV) worldwide since 1980, and to determine the global variation …

The introduction of highly active antiretroviral therapy (HAART) has decreased the incidence
and prevalence of several oral manifestations such as oral candidiasis, hairy leukoplakia …

Human immunodeficiency virus‐related oral lesions (HIV‐OL s), such as oral candidiasis
(OC) and oral hairy leukoplakia (OHL), have been recognized as indicators of immune …

Residual mucosal inflammation along with chronic systemic immune activation is an
important feature in individuals infected with human immunodeficiency virus (HIV), and has …

There were 36.9 million in the world living with human immunodeficiency virus (HIV)
infection/acquired immunodeficiency syndrome (AIDS) as of 2017, and new infections have …

Residual systemic inflammation and mucosal immune dysfunction persist in people living
with HIV, despite treatment with combined anti-retroviral therapy, but the underlying immune …

Aim: To determine the preponderance of oral mucosal lesions and conditions in patients
receiving highly active antiretroviral therapy (HAART) for Human Immunodeficiency virus …

Materials and Methods: A total of 72 HIV positive patients on ART reporting at ART centre at
Raichur District hospital were screened in the study for periodontal status, oral …

Objective: Nowadays, necrotizing periodontal diseases have a low prevalence; however, a
better understanding of the etiopathogenesis of these diseases is necessary for determining …